Our Company

QuantuMDx Group was founded in early 2008 by Elaine Warburton,
Jonathan O’Halloran and Julian Warburton.

The Company’s humble beginnings began over ten years’ ago in Jonathan’s garage where he re-arranged chemicals, reagents and biological processes and sensed them using computer transistors which provided sufficient proof of principle for his novel nucleic acid sequencing technology. Elaine, using her healthcare background and extensive commercial experience harnessed Jonathan’s technology to develop it into commercially viable and simple to use devices to meet many of today’s health challenges.

QuantuMDx is now leveraging its global network and expertise across many fields and has developed a suite of diagnostic and sequencing bio-chips capable of being assembled into a wealth of low cost but highly accurate handheld devices for the next generation of doctors, health professionals, scientists, vets, military and police.

From our years spent delivering healthcare in hospitals, diagnostics in path labs, negotiating with health funders and bringing medical and genetic innovation into mainstream medicine, we believe we are well placed to understand what doctors, health practitioners, vets, health funders and importantly patients need to effect a successful diagnosis leading to the optimum care pathway.

We continue to undertake extensive research across the globe – from township clinics to state-of-the-art hospitals - to find out exactly what our customers want from our medical devices